Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. [electronic resource]
Producer: 20040909Description: 1352-6 p. digitalISSN:- 0887-6924
- Animals
- Benzamides
- Cell Division -- drug effects
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Drug Delivery Systems
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- pharmacology
- Fusion Proteins, bcr-abl -- analysis
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mice
- Piperazines -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Treatment Outcome
- src-Family Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.